Literature DB >> 12384383

In vivo penicillin MIC drift to extremely high resistance in Serotype 14 Streptococcus pneumoniae persistently colonizing the nasopharynx of an infant with chronic suppurative lung disease: a case study.

Amanda J Leach1, Peter S Morris, Heidi Smith-Vaughan, John D Mathews.   

Abstract

This is the first report of in vivo pneumococcal penicillin MIC drift from 4.0 to 16.0 mg/liter, possibly associated with alterations in the pbp1a gene. The case presented here is of an infant with early onset recurrent pneumonia and chronic bronchitis requiring repeated antibiotics.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12384383      PMCID： PMC128758          DOI： 10.1128/AAC.46.11.3648-3649.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Molecular epidemiology of multiple drug resistant type 6B Streptococcus pneumoniae in the Northern Territory and Queensland, Australia.

Authors:  J B Carlisle; M Gratten; A J Leach
Journal:  Epidemiol Infect       Date:  2001-02       Impact factor: 2.451

2.  Non-Penicillin-Binding protein mediated high-level penicillin and cephalosporin resistance in a Hungarian clone of Streptococcus pneumoniae.

Authors:  A M Smith; K P Klugman
Journal:  Microb Drug Resist       Date:  2000       Impact factor: 3.431

3.  Alterations in PBP 1A essential-for high-level penicillin resistance in Streptococcus pneumoniae.

Authors:  A M Smith; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

4.  Penicillin minimum inhibitory concentration drift in identical sequential Streptococcus pneumoniae isolates from colonized healthy infants.

Authors:  B A Sisson; G Buck; S M Franco; L J Goldsmith; G P Rabalais
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

5.  Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s.

Authors:  S Soares; K G Kristinsson; J M Musser; A Tomasz
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

6.  Alterations in MurM, a cell wall muropeptide branching enzyme, increase high-level penicillin and cephalosporin resistance in Streptococcus pneumoniae.

Authors:  A M Smith; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

7.  Invasive pneumococcal disease in the Northern Territory of Australia, 1994-1998.

Authors:  V L Krause; S J Reid; A Merianos
Journal:  Med J Aust       Date:  2000-10-02       Impact factor: 7.738

Review 8.  Antibiotic resistance in Streptococcus pneumoniae.

Authors:  P J Collignon; J D Turnidge
Journal:  Med J Aust       Date:  2000-10-02       Impact factor: 7.738

9.  Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae.

Authors:  R Muñoz; T J Coffey; M Daniels; C G Dowson; G Laible; J Casal; R Hakenbeck; M Jacobs; J M Musser; B G Spratt
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

10.  Extensive re-modelling of the transpeptidase domain of penicillin-binding protein 2B of a penicillin-resistant South African isolate of Streptococcus pneumoniae.

Authors:  C G Dowson; A Hutchison; B G Spratt
Journal:  Mol Microbiol       Date:  1989-01       Impact factor: 3.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.